Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Tone Deaf: FDA Commissioner Hits the Wrong Note

Jun 01 2007

• By Ramsey Baghdadi

Related Content

McClellan Leads the Way to New Postmarketing World

Jun 01 2007

IoM's Sheila Burke on the Drug Safety Climate

May 01 2007

FDA's Temple of Wisdom: The Dean of Drug Development

May 01 2007

The Death of Arcoxia: Drug Regulation in a "Whistleblower" Climate

May 01 2007

Rethinking Phase IV: Congress Wants to Get Tough on Post-Marketing Requirements, but FDA May Soften the Blow

May 01 2007

The Politics of Drug Safety: An FDA Whistleblower's Push for Reform

Mar 01 2007

Related Companies

GSK plc

Sanofi

Barr Pharmaceuticals

Eli Lilly and Company

Additional Topics

Leadership Regulation BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window